These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 30589188)

  • 1. Breaking the Fourth Wall: Modulating Quaternary Associations for Protein Regulation and Drug Discovery.
    Long MJC; Hnedzko D; Kim BK; Aye Y
    Chembiochem; 2019 May; 20(9):1091-1104. PubMed ID: 30589188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of Protein-Protein Interactions for the Development of Novel Therapeutics.
    Petta I; Lievens S; Libert C; Tavernier J; De Bosscher K
    Mol Ther; 2016 Apr; 24(4):707-18. PubMed ID: 26675501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In silico structure-based approaches to discover protein-protein interaction-targeting drugs.
    Shin WH; Christoffer CW; Kihara D
    Methods; 2017 Dec; 131():22-32. PubMed ID: 28802714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small-molecule stabilization of protein-protein interactions: an underestimated concept in drug discovery?
    Thiel P; Kaiser M; Ottmann C
    Angew Chem Int Ed Engl; 2012 Feb; 51(9):2012-8. PubMed ID: 22308055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural products used as a chemical library for protein-protein interaction targeted drug discovery.
    Jin X; Lee K; Kim NH; Kim HS; Yook JI; Choi J; No KT
    J Mol Graph Model; 2018 Jan; 79():46-58. PubMed ID: 29136547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging roles of allosteric modulators in the regulation of protein-protein interactions (PPIs): A new paradigm for PPI drug discovery.
    Ni D; Lu S; Zhang J
    Med Res Rev; 2019 Nov; 39(6):2314-2342. PubMed ID: 30957264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stabilization of protein-protein interactions in drug discovery.
    Andrei SA; Sijbesma E; Hann M; Davis J; O'Mahony G; Perry MWD; Karawajczyk A; Eickhoff J; Brunsveld L; Doveston RG; Milroy LG; Ottmann C
    Expert Opin Drug Discov; 2017 Sep; 12(9):925-940. PubMed ID: 28695752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hotspot Identification and Drug Design of Protein-Protein Interaction Modulators Using the Fragment Molecular Orbital Method.
    Monteleone S; Fedorov DG; Townsend-Nicholson A; Southey M; Bodkin M; Heifetz A
    J Chem Inf Model; 2022 Aug; 62(16):3784-3799. PubMed ID: 35939049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allosteric Modulators of Protein-Protein Interactions (PPIs).
    Ni D; Liu N; Sheng C
    Adv Exp Med Biol; 2019; 1163():313-334. PubMed ID: 31707709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Network analysis and in silico prediction of protein-protein interactions with applications in drug discovery.
    Murakami Y; Tripathi LP; Prathipati P; Mizuguchi K
    Curr Opin Struct Biol; 2017 Jun; 44():134-142. PubMed ID: 28364585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computational probing protein-protein interactions targeting small molecules.
    Wang YC; Chen SL; Deng NY; Wang Y
    Bioinformatics; 2016 Jan; 32(2):226-34. PubMed ID: 26415726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benchmark Study Based on 2P2I
    Wang Z; Kang Y; Li D; Sun H; Dong X; Yao X; Xu L; Chang S; Li Y; Hou T
    J Phys Chem B; 2018 Mar; 122(9):2544-2555. PubMed ID: 29420886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitors of protein-protein interactions (PPIs): an analysis of scaffold choices and buried surface area.
    Ran X; Gestwicki JE
    Curr Opin Chem Biol; 2018 Jun; 44():75-86. PubMed ID: 29908451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current Challenges and Opportunities in Designing Protein-Protein Interaction Targeted Drugs.
    Shin WH; Kumazawa K; Imai K; Hirokawa T; Kihara D
    Adv Appl Bioinform Chem; 2020; 13():11-25. PubMed ID: 33209039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PPI inhibitor and stabilizer development in human diseases.
    Bosch J
    Drug Discov Today Technol; 2017 Jun; 24():3-9. PubMed ID: 29233297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fragment-based drug discovery supports drugging 'undruggable' protein-protein interactions.
    Wang ZZ; Shi XX; Huang GY; Hao GF; Yang GF
    Trends Biochem Sci; 2023 Jun; 48(6):539-552. PubMed ID: 36841635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative analysis and assessment of M. tuberculosis H37Rv protein-protein interaction datasets.
    Zhou H; Wong L
    BMC Genomics; 2011 Nov; 12 Suppl 3(Suppl 3):S20. PubMed ID: 22369691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular glues to stabilise protein-protein interactions.
    Soini L; Leysen S; Davis J; Ottmann C
    Curr Opin Chem Biol; 2022 Aug; 69():102169. PubMed ID: 35749929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of α-helix-mediated protein-protein interactions using designed molecules.
    Azzarito V; Long K; Murphy NS; Wilson AJ
    Nat Chem; 2013 Mar; 5(3):161-73. PubMed ID: 23422557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-level bioinformatics resources support drug target discovery of protein-protein interactions.
    Liu JX; Zhang X; Huang YQ; Hao GF; Yang GF
    Drug Discov Today; 2024 May; 29(5):103979. PubMed ID: 38608830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.